Monitoring antifactor Xa activity of the low-molecular-weight heparins in the clinical setting: who, why, how, and when?
Kalus
James S
JS
Hartford Hospital, USA.
White
C Michael
CM
D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans
D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight